MAPT and Alzheimer disease: In the case of AD, it is conventionally thought that, although β-amyloid plaques are the first manifestation of disease, tau protein aggregates are a necessary prerequisite for cell death and neurodegeneration (Kametani and Hasegawa, 2018).